Cybin logo

Cybin Share Price Today

(NASDAQ: CYBN)

Cybin share price is $7.81 & ₹679.23 as on 6 Mar 2025, 2.30 'hrs' IST

$7.81

0.35

(4.69%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cybin share price in Dollar and Rupees. Guide to invest in Cybin stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cybin, along with analyst recommendations, forecasts, and comprehensive financials.

Cybin share price movements

  • Today's Low: $7.50
    Today's High: $8.00

    Day's Volatility :6.24%

  • 52 Weeks Low: $6.50
    52 Weeks High: $19.85

    52 Weeks Volatility :67.26%

Cybin (CYBN) Returns

PeriodCybin IncIndex (Russel 2000)
3 Months
-29.89%
0.0%
6 Months
-10.07%
0.0%
1 Year
-38.54%
0.0%
3 Years
-75.37%
-11.6%

Cybin (CYBN) Key Statistics

in dollars & INR

Previous Close
$7.46
Open
$7.55
Today's High
$7.999
Today's Low
$7.5
Market Capitalization
$153.7M
Today's Volume
$35.6K
52 Week High
$19.8512
52 Week Low
$6.5
Revenue TTM
$0.0
EBITDA
$-135.0M
Earnings Per Share (EPS)
$-3.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-57.49%

How to invest in Cybin Stock (CYBN) from India?

It is very easy for Indian residents to invest directly in Cybin from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cybin stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cybin or CYBN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cybin or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cybin shares which would translate to 0.111 fractional shares of Cybin as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cybin, in just a few clicks!

Returns in Cybin (CYBN) for Indian investors in Rupees

The Cybin stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cybin investment value today

Current value as on today

₹69,296

Returns

₹30,704

(-30.7%)

Returns from Cybin Stock

₹35,667 (-35.67%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Cybin (CYBN)

119%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cybin Stock from India on INDmoney has increased by 119% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Cybin

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Cybin(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Cybin Stock (CYBN)

What analysts predicted

Upside of 1037.11%

Target:

$88.81

Current:

$7.81

Insights on Cybin Stock (Ticker Symbol: CYBN)

  • Price Movement

    In the last 1 month, CYBN stock has moved down by -24.5%
  • CYBN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 101.0%
  • CYBN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 125.8%

Cybin Technicals Summary

Sell

Neutral

Buy

Cybin is currently in a neutral trading position according to technical analysis indicators.

Cybin (CYBN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cybin Inc logo
-24.19%
-10.07%
-38.54%
-75.37%
-92.89%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cybin Inc logo
NA
NA
NA
-4.95
-0.57
-0.44
NA
12.01
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cybin Inc logo
Buy
$153.7M
-92.89%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Cybin

Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. The company's development pipeline includes CYB003, a deuterated psilocybin analog, which is in phase 1/2a clinical trial to treat major depressive disorder (MDD), as well as in preclinical trials for alcohol use disorder; CYB004, a deuterated dimethyltryptamine (DMT), which completed phase 2 clinical trial for treating generalized anxiety disorders; SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 completed phase 1, 1b, and 1/2a for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat neuroinflammation, as well as has a research pipeline of investigational psychedelic-based compounds. The company has research and collaboration agreement with TMS Neurohealth Centers Inc. for development of psychedelic compound-based therapeutics; Kernel for use of Kernel flow technology to measure neural activity; and Greenbook TMS to establish mental health centers. It also has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.
Organization
Cybin
Employees
50
CEO
Mr. Douglas L. Drysdale
Industry
Miscellaneous

Management People of Cybin

NameTitle
Mr. Eric So L.L.B.
Co-Founder, President & Executive Chairman
Mr. Douglas L. Drysdale
Chief Executive Officer
Mr. Paul Glavine
Co-Founder, Chief Growth Officer & Director
Mr. Greg Cavers
Chief Financial Officer
Mr. Aaron Bartlone
Chief Operating Officer
Mr. George Tziras
Chief Business Officer & Director
Mr. John Kanakis
Co-Founder
Dr. Alex L. Nivorozhkin Ph.D.
Chief Scientific Officer
Ms. Lori Challenger
Chief Compliance, Ethics & Administrative Officer
Mr. Gabriel Fahel
Chief Legal Officer & Corporate Secretary

Important FAQs about investing in CYBN Stock from India :

What is Cybin share price today?

Cybin share price today stands at $7.81, Open: $7.55 ; Previous Close: $7.46 ; High: $8.00 ; Low: $7.50 ; 52 Week High: $19.85 ; 52 Week Low: $6.50.

The stock opens at $7.55, after a previous close of $7.46. The stock reached a daily high of $8.00 and a low of $7.50, with a 52-week high of $19.85 and a 52-week low of $6.50.

Can Indians buy Cybin shares?

Yes, Indians can invest in the Cybin (CYBN) from India.

With INDmoney, you can buy Cybin at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cybin at zero transaction cost.

How can I buy Cybin shares from India?

It is very easy to buy Cybin from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cybin (CYBN) be purchased?

Yes, you can buy fractional shares of Cybin with INDmoney app.

What are the documents required to start investing in Cybin stocks?

To start investing in Cybin, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cybin Stock (CYBN)?

Today’s highest price of Cybin (CYBN) is $8.00.

Today’s lowest price of Cybin (CYBN) is $7.50.

What is today's market capitalisation of Cybin?

Today's market capitalisation of Cybin CYBN is 153.7M

What is the 52 Week High and Low Range of Cybin Stock (CYBN)?

  • 52 Week High

    $19.85

  • 52 Week Low

    $6.50

What are the historical returns of Cybin (CYBN)?

  • 1 Month Returns

    -24.19%

  • 3 Months Returns

    -10.07%

  • 1 Year Returns

    -38.54%

  • 5 Years Returns

    -92.89%

Who is the Chief Executive Officer (CEO) of Cybin ?

Mr. Douglas L. Drysdale is the current Chief Executive Officer (CEO) of Cybin.